Skip navigation

Strategies to Scale the Business and Best Practices for Accounting and Reporting

September 24-25, 2019
  • Boston, MA

CBI’s 3rd Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting convenes nearly 200 senior-level executives and hones-in on the unique challenges faced by small and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

Valuable Content on
High-Impact Issues, Including:

  • Healthcare industry critical updates
  • Emerging global risks and international market considerations
  • Technical accounting hot topics and best practices in
    SEC reporting
  • Talent sourcing, retention and team building
  • Investor relations and communicating to the external market
  • Roadmaps for commercializing new products
  • Models for clinical cost management, forecasts and accruals
  • Playbook on gross-to-net management
  • Considerations for IPOs, SOX controls and scaling the business
  • SEC oversight and regulatory trends
  • Implementing financial systems, automation and
    ERP lessons learned

Choose from Two Tracks of
Sessions, Tailored for:

I.  Clinical-Stage Companies

II.  Commercial-Stage Companies

A Valuable Learning and Networking Experience, Highly Rated By Peers!

Timely topics, excellent presenters, lively engaged audience and excellent networking opportunity!

CFO, Contrafect

Extremely well run with valuable
content and programming.

Partner, White & Williams LLP

The conference provided a great discussion and better understanding on relevant issues impacting us, while allowing participants to gain insights and best
practices from the speakers.

Anonymous

The conference addressed many hot topics that
are faced by fast growing biotechs!

Anonymous

A great conference. I enjoyed the technical learning sessions, then followed up with the industry panel discussions for participants to understand how these issues are incorporated into the real world.

Controller, KSQ Therapeutics, Inc.

Great topics and incredible attendees.

Partner, White & Williams LLP